Filter Results:
(3,186)
Show Results For
- All HBS Web
(3,186)
- People (7)
- News (425)
- Research (2,392)
- Events (1)
- Multimedia (5)
- Faculty Publications (1,968)
Show Results For
- All HBS Web
(3,186)
- People (7)
- News (425)
- Research (2,392)
- Events (1)
- Multimedia (5)
- Faculty Publications (1,968)
- November 2009 (Revised March 2010)
- Case
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
By: Richard G. Hamermesh, Raju Kucherlapati and Rachel Gordon
In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had... View Details
Keywords: Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Marketing Strategy; Product Positioning; Genetics; Biotechnology Industry; Europe; United States
Hamermesh, Richard G., Raju Kucherlapati, and Rachel Gordon. "Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story." Harvard Business School Case 810-066, November 2009. (Revised March 2010.)
- August 2009 (Revised April 2012)
- Case
Genzyme's CSR Dilemma: How to Play its HAND
By: Christopher A. Bartlett, Tarun Khanna and Prithwiraj Choudhury
Genzyme, a global biotechnology company, launches a program to develop therapies for neglected diseases (e.g., malaria, TB), giving away the intellectual property. This case focuses on the decision of which diseases, which partnerships, and which markets should... View Details
Keywords: Global Strategy; Health Care and Treatment; Intellectual Property; Corporate Social Responsibility and Impact; Partners and Partnerships; Research and Development; Biotechnology Industry
Bartlett, Christopher A., Tarun Khanna, and Prithwiraj Choudhury. "Genzyme's CSR Dilemma: How to Play its HAND." Harvard Business School Case 910-407, August 2009. (Revised April 2012.)
- 15 Aug 2005
- HBS Case
Classic Cases Live On at HBS
dollars for that?' They come to grips with the idea that physical appearance plays a part in how you price a car, but with an industrial product, it's all about the value you create." Hernias R Us Case: Shouldice Hospital Limited... View Details
Keywords: by Garry Emmons
- April 1995 (Revised August 1995)
- Supplement
Empire Blue Cross and Blue Shield (F)
By: Regina E. Herzlinger and Ramona Hilgenkamp
Supplements the (A) case. View Details
Herzlinger, Regina E., and Ramona Hilgenkamp. "Empire Blue Cross and Blue Shield (F)." Harvard Business School Supplement 195-221, April 1995. (Revised August 1995.)
- July 2014
- Teaching Note
Vaxess Technologies, Inc.
By: John A. Quelch
- October 2012
- Supplement
Olympus (B)
By: Jay W. Lorsch, Suraj Srinivasan and Kathleen Durante
This case outlines Michael Woodford's awards and honors, after having been fired from Olympus in October 2011. It discusses the repercussions following an investigation into the fraud and the report that was released thereafter. It also discusses the lawsuit that... View Details
Lorsch, Jay W., Suraj Srinivasan, and Kathleen Durante. "Olympus (B) ." Harvard Business School Supplement 413-075, October 2012.
- November 2011 (Revised February 2012)
- Case
China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise
By: Vicki Sato, Christoph Jaeker and Pooja Mehta Solanki
As the head of the Novartis Institute for Biomedical Research in China, En Li was shepherding a $1 billion R&D investment in China. So far he had been able to attract a large number of Chinese-born but US-trained scientists to play a critical role in establishing the... View Details
Keywords: Globalized Firms and Management; Research; Corporate Strategy; Pharmaceutical Industry; Pharmaceutical Industry; China
Sato, Vicki, Christoph Jaeker, and Pooja Mehta Solanki. "China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise." Harvard Business School Case 612-048, November 2011. (Revised February 2012.)
- December 2010
- Supplement
Urban Water Partners (A) Spreadsheet Solutions (CW)
By: Karthik Ramanna and George Serafeim
Teaching Note for Spreadsheet (111701). View Details
- December 2010
- Teaching Note
Roche's Acquisition of Genentech (TN)
By: Bo Becker and Carliss Y. Baldwin
Teaching Note for 210-040. View Details
- April 2010
- Teaching Note
Wyeth Pharmaceuticals: Spurring Scientific Creativity with Metrics
Teaching Note for [607008]. View Details
- March 2009
- Teaching Note
Proteus Biomedical: Making Pigs Fly (TN)
Teaching Note for [809051]. View Details
- November 2007 (Revised August 2014)
- Case
D2Hawkeye: Growing the Medical IT Enterprise
By: Robert F. Higgins, Rosie O'Donnell, Sophie LaMontagne and Brent Kazan
In mid-March 2007, Chris Kryder sat in his office and thought about how to best finance his company's growth. Over the previous five years as founder and CEO of D2Hawkeye, a Waltham, Massachusetts-based healthcare analytics company, Kryder had grown the firm from a... View Details
Keywords: Strategy Development; Strategic Positioning; Strategic Vision; Venture Capital; Small Business; Investment; Growth Management; Expansion; Business Growth and Maturation; Decision Choices and Conditions; Financing and Loans; Business Startups; Financial Strategy; Business Strategy; Service Industry; Service Industry; Waltham
Higgins, Robert F., Rosie O'Donnell, Sophie LaMontagne, and Brent Kazan. "D2Hawkeye: Growing the Medical IT Enterprise." Harvard Business School Case 808-006, November 2007. (Revised August 2014.)
- December 2005 (Revised May 2007)
- Case
Cynthia Fisher and the Rearing of ViaCell
By: Robert F. Higgins, Richard G. Hamermesh and Ingrid Vargas
Describes the start up of Viacord, a Boston-based medical services firm founded by Cynthia Fisher (HBS MBA) in 1993. Told from Fisher's perspective, the entrepreneur details the conceptualization and launch of the business and the many obstacles and expenses faced in... View Details
Keywords: Managerial Roles; Business Growth and Maturation; Entrepreneurship; Business Startups; Service Industry; Service Industry; Boston
Higgins, Robert F., Richard G. Hamermesh, and Ingrid Vargas. "Cynthia Fisher and the Rearing of ViaCell." Harvard Business School Case 806-002, December 2005. (Revised May 2007.)
- April 2000
- Teaching Note
Patient Care Delivery Model at the Massachusetts General Hospital, The TN
By: Amy C. Edmondson, Richard M.J. Bohmer and Emily Heaphy
Teaching Note for (9-699-154). View Details
- July 1985 (Revised January 1988)
- Case
American Hospital Supply Corp.: The ASAP System (A)
American Hospital Supply, the largest firm in the U.S. hospital supply industry, has achieved success in part through the use of information systems. Changes in the hospital marketplace suggest a shift in strategy would be appropriate. What role should information... View Details
Keywords: Information Technology; Order Taking and Fulfillment; Distribution Industry; Distribution Industry; United States
Vitale, Michael R. "American Hospital Supply Corp.: The ASAP System (A)." Harvard Business School Case 186-005, July 1985. (Revised January 1988.)
- April 1975 (Revised November 1987)
- Case
Medibus, Inc.
By: W. Earl Sasser
Sasser, W. Earl. "Medibus, Inc." Harvard Business School Case 675-177, April 1975. (Revised November 1987.)
- 17 Dec 2001
- Research & Ideas
Becoming the Next Real Estate Mogul
"There were a lot of eyes on that project," Palandjian said. "It was gratifying on many levels, particularly because we renovated the building to a proper use—it could have just as easily been turned into a health... View Details
- 29 Aug 2024
- Blog Post
Leni Peterson R. (MS/MBA 2023): Solving Big Problems Through Entrepreneurship
Without water, companies cannot operate. Water is not only a key indicator of climate change, but also a major factor behind supply chain disruptions. Poor water access can exacerbate health and political crises through flooding,... View Details
- 17 Apr 2024
- Blog Post
New Venture Competition 2024: Business and Environment Ventures
individual cow health and behavior, empowering farmers and providing peace of mind as they make better high-value livestock management decisions on breeding, disease, and feed programs. EnergAI - Aron Sass (MBA 2025), Balint Varga -... View Details
- 2014
- Working Paper
Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms
By: Prithwiraj Choudhury and Tarun Khanna
Since the 1990s, several Western firms have filed patents based on medicinal herbs from emerging markets, evoking protests from local stakeholders against 'bio-piracy'. We explore conditions under which firms and local stakeholders share rents from such patents. Our... View Details
Keywords: Rents From New Technology; Local Stakeholders; Herbal Patents; QCA; Fuzzy Set Analysis; Qualitative Case Studies; Plant-Based Agribusiness; Patents; Emerging Markets; Health Care and Treatment; Business and Stakeholder Relations; Cross-Cultural and Cross-Border Issues; Agriculture and Agribusiness Industry; Agriculture and Agribusiness Industry
Choudhury, Prithwiraj, and Tarun Khanna. "Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms." Harvard Business School Working Paper, No. 14-081, February 2014.